Meeting
2022 ASCO Annual Meeting
Piflufolastat f 18-PET/CT in patients with prostate cancer: An analysis of OSPREY (cohorts A and B) standardized uptake value (SUV) results stratified by PSA and Gleason score.
Authors
Michael A. Gorin
Johns Hopkins University School of Medicine, Baltimore, MD
Michael A. Gorin , Steven P. Rowe , Kenneth J. Pienta , Peter R. Carroll , Frederic Pouliot , Stephan Probst , Lawrence Saperstein , Mark Preston , Ajjai Shivaram Alva , Akash Patnaik , Nancy Stambler , Barry A. Siegel , Michael J. Morris
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Genitourinary Cancer—Prostate, Testicular, and Penile
Track
Genitourinary Cancer—Prostate, Testicular, and Penile
Sub Track
Epidemiology/Outcomes
Clinical Trial Registration Number
NCT02981368
Citation
J Clin Oncol 40, 2022 (suppl 16; abstr 5024)
DOI
10.1200/JCO.2022.40.16_suppl.5024
Abstract #
5024
Poster Bd #
208
Abstract Disclosures
Similar Posters
Poster
2022 ASCO Genitourinary Cancers Symposium
Piflufolastat F 18-PET/CT in prostate cancer patients: An analysis of OSPREY (Cohorts A and B) standardized uptake value (SUV) results stratified by PSA and gleason score.
First Author: Michael A. Gorin
Poster
2024 ASCO Genitourinary Cancers Symposium
Association of aggressive prostate cancer features on whole-mount histopathology and quantitative measures on PSMA PET.
First Author: Ida Sonni
Poster
2024 ASCO Genitourinary Cancers Symposium
Utility of PSMA PET/CT for imaging ductal carcinoma of the prostate.
First Author: Ahmed M. Mahmoud
Poster
2024 ASCO Genitourinary Cancers Symposium
Imaging predictive biomarkers of response in patients with prostate cancer undergoing high-intensity focused ultrasound (HIFU) focal therapy.
First Author: Egesta Lopci